The move would reverse the company's $78 billion acquisition of Aetna, and dismantle the vertically integrated healthcare conglomerate it created in 2018.
Jeff deGraaf, Renaissance Macro Research chairman, joins 'Closing Bell' to discuss the latest in the markets. Got a ...
Mark Okada, Sycamore Tree Capital Partners co-founder and CEO, joins 'Closing Bell' to discuss the midterms, markets, and ...
The next debt-ceiling confrontation could reverse Washington's traditional political roles, raising the possibility of ...
CNBC's TechCheck brings you the latest in tech news from CNBC's 1 Market in the heart of San Francisco.
Tom Lee, Fundstrat managing partner and head of research and Fundstrat Capital CIO, joins 'Closing Bell' to discuss the ...
CNBC’s Oliver Renick joins ‘Closing Bell’ to report on the latest Options Action.  Got a confidential news tip? We want to ...
CNBC's Eamon Javers reports on talking with President Trump on working with Democrats after the midterms. Got a confidential ...
Crude oil prices fell more than 4% on Wednesday after Vice President JD Vance blamed the Republicans' steep midterm election ...
Analysts say that after a roughly two-year turnaround the company's retail pharmacy business and other units may be strong ...
Blue wave gives Democrats control of Congress. Here's how their agenda could affect your money, from health care and taxes to ...
Liz Ann Sonders, chief investment strategist at Schwab Center for Financial Research, joins 'Closing Bell' to discuss the ...